Ritonavir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 24 USDMF, 11 CEP/COS, 9 EU WC, 3 KDMF, 10 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

62 Drugs in Development

62 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers, 41 FDA Orange Book, 18 Europe, 7 Canada, 1 Australia, 25 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 100MG;25MG, TABLET;ORAL - 200MG;50MG, TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Rochem International Inc, 1 SPI Pharma, 1 Seqens, 8 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 Bioplus Life Sciences, 1 Clariant, 12 Corel Pharma Chem, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 6 Ideal Cures Pvt Ltd, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 3 Roquette, 15 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

52 Coating Systems & Additives, 34 Solubilizers, 29 Fillers, Diluents & Binders, 25 Controlled & Modified Release, 22 Film Formers & Plasticizers, 21 Parenteral, 18 Topical, 17 Emulsifying Agents, 15 Thickeners and Stabilizers, 15 Direct Compression, 12 Lubricants & Glidants, 12 Taste Masking, 11 Granulation, 10 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 7 Disintegrants & Superdisintegrants, 6 Co-Processed Excipients, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 Rheology Modifiers

DIGITAL CONTENT

6 DATA COMPILATION #PharmaFlow, 3 STOCK RECAP #PipelineProspector, 153 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 15 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

24 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

31 US Patents, 16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 3 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 208624 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Drug Product Composition: Ritonavir

Ritonavir

Ritonavir

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers

24 USDMF

11 CEP/COS

9 EU WC

3 KDMF

10 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

62 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers

41 FDA Orange Book

18 Europe

7 Canada

1 Australia

25 South Africa

15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG;25MG

TABLET;ORAL - 200MG;50MG

TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

1 Minakem

3 Rochem International Inc

1 SPI Pharma

1 Seqens

8 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

2 Faran Shimi Pharmaceutical

6 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

5 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

4 ACG Worldwide

7 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

2 Bioplus Life Sciences

1 Clariant

12 Corel Pharma Chem

1 Finar

13 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

6 Ideal Cures Pvt Ltd

14 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

4 Novo Excipients

2 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

3 Roquette

15 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Sigachi Industries

2 The Dow Chemical Company

1 Ulanqab Kema New Material

TABLET;ORAL - 12.5MG;75MG;50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons